IPO - Cellectar Biosciences, Inc.

Form Type: CORRESP

Filing Date: 2025-02-04

Corporate Action: Ipo

Type: New

Accession Number: 000110465925009108

Filing Summary: Cellectar Biosciences, Inc. has requested the Securities and Exchange Commission to accelerate the effective date of its Registration Statement on Form S-1 (Registration No. 333-284580) filed on January 29, 2025. The company aims for the registration to become effective at 5:00 p.m. on February 6, 2025, or as soon as practicable thereafter. This request indicates the company's intention to proceed with an initial public offering (IPO). The company expresses appreciation for the staff's cooperation and provides contact information for any questions or comments.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-29

Corporate Action: Ipo

Type: New

Accession Number: 000141057825000060

Filing Summary: Cellectar Biosciences, Inc. filed a Form S-1 registration statement with the SEC on January 29, 2025. This registration statement relates to the proposed initial public offering (IPO) of shares of common stock. The company aims to raise capital for funding its ongoing research and development activities, expanding its operational capabilities, and for general corporate purposes. The S-1 includes detailed information regarding the company's business model, financial statements, risk factors, management structure, and use of proceeds from the offering. The document outlines the terms of the offering, including the number of shares to be offered and anticipated pricing, which will be finalized during the marketing period prior to the IPO.

Document Link: View Document